Detalhe da pesquisa
1.
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
Inflammopharmacology
; 32(1): 433-446, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477795
2.
New Oxazolidines Inhibit the Secretion of IFN-γ and IL-17 by PBMCS from Moderate to Severe Asthmatic Patients.
Med Chem
; 17(3): 289-297, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914717
3.
Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study.
Autoimmunity
; 54(4): 187-194, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973825